New onset steatosis but not persistent steatosis prevents hepatic fibrosis improvement after viral eradication by direct-acting antiviral therapy (DAAs) in patients with chronic hepatitis C: Evaluation by controlled attenuation parameter (CAP) and liver stiffness measurement LSM

2021 ◽  
Vol 53 ◽  
pp. S16
Author(s):  
A. Cespiati ◽  
S. Petta ◽  
R. Lombardi ◽  
V. Di Marco ◽  
V. Calvaruso ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document